scholarly journals A Study on the Virus-Like Particle Formation of Hepatitis E Virus ORF2 and Rotavirus NSP4 Protein in the Eukaryotic and Prokaryotic Expression Systems

2017 ◽  
Vol 10 (12) ◽  
Author(s):  
Manoochehr Makvandi ◽  
Ali Teimoori ◽  
Niloofar Neisi ◽  
Alireza Samarbafzadeh
Virology ◽  
2020 ◽  
Vol 544 ◽  
pp. 1-11 ◽  
Author(s):  
Zhenzhen Liu ◽  
Nouredine Behloul ◽  
Sarra Baha ◽  
Wenjuan Wei ◽  
Wanru Tao ◽  
...  

Author(s):  
Che-Yen Wang ◽  
Naoyuki Miyazaki ◽  
Tetsuo Yamashita ◽  
Akifumi Higashiura ◽  
Atsushi Nakagawa ◽  
...  

2019 ◽  
Author(s):  
Tianyu LU ◽  
Nouredine BEHLOUL ◽  
Yi ZHOU ◽  
Sarra BAHA ◽  
Zhenzhen LIU ◽  
...  

Abstract Background: Virus like particle (VLP), a multiprotein structure which is assembled automatically, can stimulate robust immune responses due to an appropriate size, repetitive epitopes, and a structure similar to native virions. Utilizing VLPs as vaccine carriers to present exogenous antigens is a promising and challenging field in vaccine design. Hence, this study aims to investigate the potential of Hepatitis E virus (HEV) truncated capsid protein as a VLP carrier presenting foreign antigens in vaccine design.Results: S and M domains of HEV ORF2 protein (aa112-455) were selected as an optimal carrier (CaSM). The exogenous antigen Seq8 containing three immunogenic domains from three different foot-and-mouth disease virus (FMDV) strains was linked to the C-terminal of CaSM to construct a chimeric VLP vaccine candidate (CaSM-Seq8). Morphological analysis showed that CaSM-Seq8 self-assembled into VLPs with a diameter of approximately 26 nm, similar to the VLPs of CaSM alone but smaller than native HEV virions. Further, the thermal stability and the proteolysis resistance of Seq8 were enhanced when carried by CaSM. The antigenicity analysis revealed a more robust reactivity against anti-FMDV specific antibodies when Seq8 was presented on the CaSM particles. Upon injection into mice, anti-FMDV IgGs induced by CaSM-Seq8 appeared earlier, increased faster, and maintained higher levels for a longer time than those induced by Seq8 antigen alone or a commercial inactivated FMDV vaccine.Conclusions: This study demonstrates the potential of the HEV truncated capsid protein VLPs as a presenting-platform of exogenous antigens in vaccine design and promising preliminary results on chimeric VLP vaccine against foot-and-mouth disease.


Vaccine ◽  
2013 ◽  
Vol 31 (2) ◽  
pp. 417-424 ◽  
Author(s):  
Pitchanee Jariyapong ◽  
Li Xing ◽  
Nienke E. van Houten ◽  
Tian-Cheng Li ◽  
Wattana Weerachatyanukul ◽  
...  

2009 ◽  
Vol 106 (31) ◽  
pp. 12992-12997 ◽  
Author(s):  
T. S. Y. Guu ◽  
Z. Liu ◽  
Q. Ye ◽  
D. A. Mata ◽  
K. Li ◽  
...  

2008 ◽  
Vol 64 (a1) ◽  
pp. C327-C327
Author(s):  
N. Miyazaki ◽  
C.-Y. Wang ◽  
A. Higashiura ◽  
A. Nakagawa ◽  
T.-C. Li ◽  
...  

2000 ◽  
Vol 62 (3) ◽  
pp. 327-333 ◽  
Author(s):  
Tian-Cheng Li ◽  
Jing Zhang ◽  
Haruhide Shinzawa ◽  
Masamichi Ishibashi ◽  
Michio Sata ◽  
...  

2011 ◽  
Vol 49 (01) ◽  
Author(s):  
C Dorloff ◽  
J Hemberger ◽  
M Odenthal ◽  
H Holzmann ◽  
S Aberle ◽  
...  

2013 ◽  
Vol 51 (01) ◽  
Author(s):  
S Schlosser ◽  
J Pflaum ◽  
K Weigand ◽  
JJ Wenzel ◽  
W Jilg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document